Fifth Eye

Fifth Eye’s mission is to provide over-burdened hospital clinicians access to unique, real-time information to:. Fifth Eye continued to work closely with physicians and nurses to develop a product that was not only accurate, but easy to integrate into their existing workflow. The approach was to create a “leading indicator” to alert clinicians to patients at risk for hemodynamic instability ahead of identification via vital signs. In December 2021, the company received FDA clearance for its second generation product, the AHI System. Serial entrepreneur and executive with over 25 years of experience in the healthcare and life science industries. AHI is the new standard for detecting and predicting hemodynamic instability. Medical device software that includes two analytics that provide a comprehensive view of a patient’s evolving hemodynamic trajectory.